Life Sciences

GSK sets aside $400M for possible settlement

Pharma Compliance Alert, February 4, 2009

GlaxoSmithKline (GSK) is preparing to settle an ongoing investigation into the company’s marketing and promotional practices for nine of its best-selling products between 1997 and 2004.

GSK announced in a January 29 press release that it was recording a legal charge of $400 million for the fourth quarter of 2008 in relation to the investigation.

Continue reading about GSK's possible $400 million settlement.


0 comments on “GSK sets aside $400M for possible settlement


Most Popular